CD31- A Complex Function MoleculeAt the 2015 ASCO Annual Meeting, the team of Michael J. Birrer, MD, et al. proposed that CD31 is a potential biomarker for bevacizumab in ovarian cancer. Because the effect of bevacizumab on progression-free survival (PF...
Detailed information